The page is the record's research on the issuer — no analyst, no rating, no view.

Telo Genomics Corp. (TELO) — research page

CA · ca-cm-kg/TSXV/TELO · as of 2026-11-06

Identity and listing

The issuer is Telo Genomics Corp., listed on the TSXV under ticker TELO, with ISIN CA87975M2085. The LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. The security type is Corporate, the sector is Life Sciences, and the segment and jurisdiction are not on the record. The issuer is listed and not halted.

fieldvaluesource · read date
nameTelo Genomics Corp.source · 2026-11-06
exchangeTSXVsource · 2026-11-06
tickerTELOsource · 2026-11-06
ISINCA87975M2085source · 2026-11-06
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 16 filings in the twelve months to 2026-11-06, across 16 filing days: 1 exchange bulletin and 15 newswire releases. The median gap between filing days is 14 days. The latest filing is dated 2026-11-06 and is a newswire release, 0 days before the record date. The TSXV median is 19 days of cadence gap, 9 filings and 17.0 days of latency across 1427 issuers. The Life Sciences median is 17.5 days of cadence gap, 7.0 filings and 14 days of latency across 200 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer16140
exchange median: TSXV (1427 issuers)91917
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-11-06newswire_releaseTelo Genomics Announces $250000 Term Loan Facility
2026-10-30newswire_releaseTELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
2026-10-29newswire_releaseTELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
2026-09-29newswire_releaseTelo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
2026-09-15newswire_releaseTelo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, as none was found, and its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move lines. The issuer is listed and not halted.

Orderability

For paragraph (o) of the definition, the outcome is signal ACM-200 and is determinable. For paragraph (q) of the definition, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page; the count is 0.

Open research

No openly published research notes were found; the count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. The issuer has no sealed years in the record. The live record began on 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)
10.2
https://ceo.ca/TELO (identity.isin)
10.3
https://www.tsx.com/en/resource/571 (identity.sector)
10.4
https://mcp.ca-cm-kg.ai/events/TSXV/TELO (the disclosure lines)
10.5
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.6
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.ca-cm-kg.ai/record/TSXV/TELO (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CA87975M2085"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:498db59a4940854f.